Global Cardiovascular Disease Market to reach USD 84.85 billion by 2027

Global Cardiovascular Disease Market Size study, by Drug Type (Antihypertensive, Antihyperlipidemic, Anticoagulants, Antiplatelet Drugs and Others), by Disease Indication (Hypertension, Hyperlipidemia, Coronary Artery Disease, Arrhythmia and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) and Regional Forecasts 2020-2027
Product Code:  OIRIA_56534246
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1.	Cardiovascular Disease Market, by Region, 2018-2027 (USD Billion)
1.2.2.	Cardiovascular Disease Market, by Drug Type, 2018-2027 (USD Billion)
1.2.3.	Cardiovascular Disease Market, by Disease Indication, 2018-2027 (USD Billion)
1.2.4.	Cardiovascular Disease Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Cardiovascular Disease Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Cardiovascular Disease Market Dynamics	
3.1.	Cardiovascular Disease Market Impact Analysis (2018-2027)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Cardiovascular Disease Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Cardiovascular Disease Market, by Drug Type
5.1.	Market Snapshot 
5.2.	Global Cardiovascular Disease Market by Application, Performance - Potential Analysis
5.3.	Global Cardiovascular Disease Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
5.4.	Cardiovascular Disease Market, Sub Segment Analysis
5.4.1.	 Antihypertensive
5.4.2.	Antihyperlipidemic
5.4.3.	Anticoagulants
5.4.4.	Antiplatelet Drugs
5.4.5.	Others
Chapter 6.	Global Cardiovascular Disease Market, by Disease Indication
6.1.	Market Snapshot 
6.2.	Global Cardiovascular Disease Market by Application, Performance - Potential Analysis
6.3.	Global Cardiovascular Disease Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4.	Cardiovascular Disease Market, Sub Segment Analysis
6.4.1.	 Hypertension
6.4.2.	Hyperlipidemia
6.4.3.	Coronary Artery Disease
6.4.4.	Arrhythmia
6.4.5.	Others
Chapter 7.	Global Cardiovascular Disease Market, by Distribution Channel
7.1.	Market Snapshot 
7.2.	Global Cardiovascular Disease Market by Application, Performance - Potential Analysis
7.3.	Global Cardiovascular Disease Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
7.4.	Cardiovascular Disease Market, Sub Segment Analysis
7.4.1.	 Hospital Pharmacies
7.4.2.	Retail Pharmacies
7.4.3.	Online Pharmacies
7.4.4.	Others
Chapter 8.	Global Cardiovascular Disease Market, Regional Analysis
8.1.	Cardiovascular Disease Market, Regional Market Snapshot 
8.2.	North America Cardiovascular Disease Market 
8.2.1.	U.S. Cardiovascular Disease Market
8.2.1.1.	Drug Type breakdown estimates & forecasts, 2017-2027
8.2.1.2.	Disease Indication breakdown estimates & forecasts, 2017-2027
8.2.1.3.	Distribution Channel breakdown estimates & forecasts, 2017-2027 
8.2.2.	Canada Cardiovascular Disease Market
8.3.	Europe Cardiovascular Disease Market Snapshot
8.3.1.	U.K. Cardiovascular Disease Market 
8.3.2.	Germany Cardiovascular Disease Market
8.3.3.	France Cardiovascular Disease Market
8.3.4.	Spain Cardiovascular Disease Market
8.3.5.	Italy Cardiovascular Disease Market
8.3.6.	Rest of Europe Cardiovascular Disease Market
8.4.	Asia-Pacific Cardiovascular Disease Market Snapshot
8.4.1.	China Cardiovascular Disease Market 
8.4.2.	India Cardiovascular Disease Market 
8.4.3.	Japan Cardiovascular Disease Market
8.4.4.	Australia Cardiovascular Disease Market
8.4.5.	South Korea Cardiovascular Disease Market
8.4.6.	Rest of Asia Pacific Cardiovascular Disease Market
8.5.	Latin America Cardiovascular Disease Market Snapshot
8.5.1.	Brazil Cardiovascular Disease Market
8.5.2.	Mexico Cardiovascular Disease Market
8.6.	Rest of The World Cardiovascular Disease Market

Chapter 9.	Competitive Intelligence
9.1.	Top Market Strategies
9.2.	Company Profiles
9.2.1.	 Bristol-Myers Squibb Company
9.2.1.1.	Key Information
9.2.1.2.	Overview
9.2.1.3.	Financial (Subject to Data Availability)
9.2.1.4.	Product Summary
9.2.1.5.	Recent Developments
9.2.2.	Pfizer Inc.
9.2.3.	Bayer AG
9.2.4.	Janssen Pharmaceuticals, Inc.
9.2.5.	AstraZeneca
9.2.6.	Sanofi
9.2.7.	Novartis AG
9.2.8.	Merck & Co., Inc.
9.2.9.	Gilead Sciences, Inc.
9.2.10.	F. Hoffmann-La Roche Ltd
Chapter 10.	Research Process
10.1.	Research Process
10.1.1.	Data Mining
10.1.2.	Analysis
10.1.3.	Market Estimation
10.1.4.	Validation
10.1.5.	Publishing
10.2.	Research Attributes
10.3.	Research Assumption

Global Cardiovascular Disease Market is valued approximately USD 63.17 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 3.9 % over the forecast period 2020-2027. Cardiovascular diseases (CVD) are precisely a cluster of disorders of the heart and blood vessels consisting of cerebrovascular disease, coronary heart disease, rheumatic heart disease and stroke. Through hypertension and dyslipidemia, the development of atherosclerotic plaque build up within blood vessels, is the risk factor for the cause of CVD. Diabetes is another disease enhance the risk of stroke and heart disease. The surging prevalence of Cardiovascular Diseases and rising incidence of diabetic patients across the world are the few factors responsible for growth of the market over the forecast period. According to International Diabetes Federation, approximately 463 million adults belonging to the age group of 20-79 years were living with diabetes in the year 2019 which is estimated to reach to around 700 million by the end of the year 2045. Also, according to World Health Organization, 4 out 5 cardiovascular deaths among both male and female population occur due to impact of strokes and heart attacks and 1/3 of these deaths occur prematurely in individuals living under the age of 70 years. However, side effects associated with cardiovascular medicine is the major factor restraining the growth of global Cardiovascular Disease market during the forecast period.

The regional analysis of global Cardiovascular Disease market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world owing to the rising awareness of numerous heart diseases in this region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:
Bristol-Myers Squibb Company
Pfizer Inc.
Bayer AG
Janssen Pharmaceuticals, Inc.
AstraZeneca
Sanofi
Novartis AG
Merck & Co., Inc.
Gilead Sciences, Inc.
F. Hoffmann-La Roche Ltd

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

by Drug Type:
Antihypertensive
Antihyperlipidemic
Anticoagulants
Antiplatelet Drugs
Others

By Disease Indication:
Hypertension
Hyperlipidemia
Coronary Artery Disease
Arrhythmia
Others

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Cardiovascular Disease Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…